A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis
Running, not enrolling · Phase 2
Conditions studied: Hepatocellular Carcinoma
In brief
The purpose of this study is to assess the safety of atezolizumab and bevacizumab, or atezolizumab alone, as first-line treatment in participants with unresectable, locally advanced or metastatic hepatocellular carcinoma (HCC) with Child-pugh B7 or B8 cirrhosis.
Key facts
- Study ID
- NCT06096779
- Run by
- Genentech, Inc.
- People needed
- 30
- Starts
- 2024-07-15
- Expected to finish
- 2027-12-30
- Last updated by the study team
- 2026-07-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UC San Diego Moores Cancer Center — La Jolla, California, United States
- Houston Methodist Hospital — Houston, Texas, United States
- University of Southern California-Keck School of Medicine -1975 Zonal Ave — Los Angeles, California, United States
- University of Southern California — Newport Beach, California, United States
- University of California Irvine Medical Center — Orange, California, United States
- California Liver Research Institute — Pasadena, California, United States
- University of California Davis Medical Center — Sacramento, California, United States
- Stanford Health Care — Stanford, California, United States
- Harbor UCLA Medical Center — Torrance, California, United States
- Cedars Sinai Comprehensive Transplant Center — West Hollywood, California, United States
- Rocky Mountain Cancer Centers (Williams) - USOR — Denver, Colorado, United States
- Hartford Healthcare Cancer Institute at Hartford Hospital — Hartford, Connecticut, United States
- George Washington University- Medical Faculty Associates — Washington D.C., District of Columbia, United States
- Washington DC VA Medical Center — Washington D.C., District of Columbia, United States
- Orlando Health Inc. — Orlando, Florida, United States
- Northwestern University — Chicago, Illinois, United States
- University of Illinois Health Outpatient Care Center — Chicago, Illinois, United States
- The Duchossois Center for Advanced Medicine — Chicago, Illinois, United States
- University of Kentucky - Markey Cancer Center — Lexington, Kentucky, United States
- LSU Health Baton Rouge — Baton Rouge, Louisiana, United States
- Our Lady of the Lake Cancer Institute — Baton Rouge, Louisiana, United States
- Tufts Medical Center — Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- Veterans Affairs Ann Arbor Healthcare System — Ann Arbor, Michigan, United States
- University of Arizona Cancer Center — Tucson, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.